Journal of Molecular and Cellular Cardiology
Volume 49, Issue 5 , Pages 771-780 , November 2010

Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents

  • Antoni Bayes-Genis

      Affiliations

    • Laboratory of Cell Physiology, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    • Corresponding Author InformationCorresponding authors. J.C.I. Belmonte is to be contacted at Gene Expression Laboratory, The Salk Institute for Biological Studies, 10010 N. Torres Pines Rd., La Jolla, CA 92037-1099, USA. Tel.: +1 858 4534100x1167; fax: +1 858 4532573. A. Bayés-Genís, Cardiology Department, Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol, Crta. Canyet, s/n, 08916 Badalona. Tel.: +34 93 4978915; fax: +34 93 4978939.
    • These three authors contributed equally to this work.
    • Present address: A. B.-G., C. S.-B., S. R., C.P.-V., and C. G.-M: Hospital Universitari Germans Trias i Pujol, Badalona, Spain; J. F.: Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; A. R.: Control of Stem Cell Potency Group, Institute for Bioengineering of Catalonia, Barcelona, Spain.
    • ,
  • Carolina Soler-Botija

      Affiliations

    • Laboratory of Cell Physiology, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    • Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA
    • These three authors contributed equally to this work.
    • Present address: A. B.-G., C. S.-B., S. R., C.P.-V., and C. G.-M: Hospital Universitari Germans Trias i Pujol, Badalona, Spain; J. F.: Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; A. R.: Control of Stem Cell Potency Group, Institute for Bioengineering of Catalonia, Barcelona, Spain.
    • ,
  • Jordi Farré

      Affiliations

    • Laboratory of Cell Physiology, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain
    • These three authors contributed equally to this work.
    • Present address: A. B.-G., C. S.-B., S. R., C.P.-V., and C. G.-M: Hospital Universitari Germans Trias i Pujol, Badalona, Spain; J. F.: Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; A. R.: Control of Stem Cell Potency Group, Institute for Bioengineering of Catalonia, Barcelona, Spain.
    • ,
  • Pilar Sepúlveda

      Affiliations

    • Unidad de Cardioregeneración, Centro de Investigación Príncipe Felipe. Fundación para la investigación Hospital La Fe, Hospital la Fe, Valencia, Spain
    • ,
  • Angel Raya

      Affiliations

    • Centre de Medicina Regenerativa de Barcelona, CMRB, Barcelona, Spain
    • Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
    • Networking Center of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain
    • Present address: A. B.-G., C. S.-B., S. R., C.P.-V., and C. G.-M: Hospital Universitari Germans Trias i Pujol, Badalona, Spain; J. F.: Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; A. R.: Control of Stem Cell Potency Group, Institute for Bioengineering of Catalonia, Barcelona, Spain.
    • ,
  • Santiago Roura

      Affiliations

    • Laboratory of Cell Physiology, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    • Present address: A. B.-G., C. S.-B., S. R., C.P.-V., and C. G.-M: Hospital Universitari Germans Trias i Pujol, Badalona, Spain; J. F.: Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; A. R.: Control of Stem Cell Potency Group, Institute for Bioengineering of Catalonia, Barcelona, Spain.
    • ,
  • Cristina Prat-Vidal

      Affiliations

    • Laboratory of Cell Physiology, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    • Present address: A. B.-G., C. S.-B., S. R., C.P.-V., and C. G.-M: Hospital Universitari Germans Trias i Pujol, Badalona, Spain; J. F.: Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; A. R.: Control of Stem Cell Potency Group, Institute for Bioengineering of Catalonia, Barcelona, Spain.
    • ,
  • Carolina Gálvez-Montón

      Affiliations

    • Laboratory of Cell Physiology, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, ICCC, Barcelona, Spain
    • Department of Cardiology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    • Present address: A. B.-G., C. S.-B., S. R., C.P.-V., and C. G.-M: Hospital Universitari Germans Trias i Pujol, Badalona, Spain; J. F.: Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; A. R.: Control of Stem Cell Potency Group, Institute for Bioengineering of Catalonia, Barcelona, Spain.
    • ,
  • José Anastasio Montero

      Affiliations

    • Unidad de Cardioregeneración, Centro de Investigación Príncipe Felipe. Fundación para la investigación Hospital La Fe, Hospital la Fe, Valencia, Spain
    • ,
  • Dirk Büscher

      Affiliations

    • Cellerix SA, Tres Cantos, Spain
    • ,
  • Juan Carlos Izpisúa Belmonte

      Affiliations

    • Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, USA
    • Centre de Medicina Regenerativa de Barcelona, CMRB, Barcelona, Spain
    • Corresponding Author InformationCorresponding authors. J.C.I. Belmonte is to be contacted at Gene Expression Laboratory, The Salk Institute for Biological Studies, 10010 N. Torres Pines Rd., La Jolla, CA 92037-1099, USA. Tel.: +1 858 4534100x1167; fax: +1 858 4532573. A. Bayés-Genís, Cardiology Department, Universitat Autònoma de Barcelona, Hospital Universitari Germans Trias i Pujol, Crta. Canyet, s/n, 08916 Badalona. Tel.: +34 93 4978915; fax: +34 93 4978939.

Received 10 December 2009 ,Revised 20 July 2010 ,Accepted 6 August 2010.

References 

  1. Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ. Res. 1991;68(3):856–869
  2. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114(6):763–766
  3. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA. 2003;100(21):12313–12318
  4. Goldstein G, Toren A, Nagler A. Human umbilical cord blood biology, transplantation and plasticity. Curr. Med. Chem. 2006;13(11):1249–1259
  5. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. NY Acad. Sci. 2001;938:221–229discussion 229-30
  6. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 2004;95(1):9–20
  7. Rangappa S, Fen C, Lee EH, Bongso A, Sim EK. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann. Thorac. Surg. 2003;75(3):775–779
  8. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428(6983):668–673
  9. Murry CE, Soonpaa MH, Reinecke H, Nakajima HO, Rubart M, Pasumarthi KB, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428(6983):664–668
  10. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106(24):3009–3017
  11. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106(15):1913–1918
  12. Dohmann HF, Silva SA, Souza AL, Braga AM, Branco RV, Haddad AF, et al. Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction: a MiHeart/AMI study. Trials. 2008;9(1):41
  13. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am. Heart J. 2007;153(6):907–917
  14. Martinez-Estrada OM, Munoz-Santos Y, Julve J, Reina M, Vilaro S. Human adipose tissue as a source of Flk-1+ cells: new method of differentiation and expansion. Cardiovasc. Res. 2005;65(2):328–333
  15. Roura S, Farre J, Soler-Botija C, Llach A, Hove-Madsen L, Cairo JJ, et al. Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells. Eur. J. Heart Fail. 2006;8(6):555–563
  16. Roura S, Planas F, Prat-Vidal C, Leta R, Soler-Botija C, Carreras F, et al. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. Eur. J. Heart Fail. 2007;9(10):995–1002
  17. Gandia C, Arminan A, Garcia-Verdugo JM, Lledo E, Ruiz A, Miñana MD, et al. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells. 2008;26(3):638–645
  18. Fukuhara S, Tomita S, Yamashiro S, Morisaki T, Yutani C, Kitamura S, et al. Direct cell–cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro. J. Thorac. Cardiovasc. Surg. 2003;125(6):1470–1480
  19. Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ, Heydarkhan S, Xu Y, Zuk PA, et al. Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells Tissues Organs. 2008;187(4):263–274
  20. Liu JW, Dunoyer-Geindre S, Serre-Beinier V, Mai G, Lambert JF, Fish RJ, et al. Characterization of endothelial-like cells derived from human mesenchymal stem cells. J. Thromb. Haemost. 2007;5(4):826–834
  21. Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC, et al. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res. 2007;17(3):240–248
  22. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147
  23. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–228
  24. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107(9):1322–1328
  25. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 2007;21(12):3197–3207
  26. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 1984;99(6):2034–2040
  27. Crabtree B, Subramanian V. Behavior of endothelial cells on Matrigel and development of a method for a rapid and reproducible in vitro angiogenesis assay. In Vitro Cell. Dev. Biol. Anim. 2007;43(2):87–94
  28. Gaustad KG, Boquest AC, Anderson BE, Gerdes AM, Collas P. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem. Biophys. Res. Commun. 2004;314(2):420–427
  29. Jumabay M, Zhang R, Yao Y, Goldhaber JI, Bostrom KI. Spontaneously beating cardiomyocytes derived from white mature adipocytes. Cardiovasc. Res. 2010;85:17–27
  30. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 2001;107(11):1395–1402
  31. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410(6829):701–705
  32. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 2006;98(11):1414–1421
  33. Mazo M, Planat-Benard V, Abizanda G, Pelacho B, Leobon B, Gavira JJ, et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur. J. Heart Fail. 2008;10(5):454–462
  34. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275(5302):964–967
  35. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation. 2003;107(10):1359–1365
  36. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002;105(7):788–793

PII: S0022-2828(10)00297-X

doi: 10.1016/j.yjmcc.2010.08.010

Journal of Molecular and Cellular Cardiology
Volume 49, Issue 5 , Pages 771-780 , November 2010

Article Tools

* Image Usage & Resolution